nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—embryo—malignant glioma	0.0286	0.145	CbGeAlD
Amcinonide—ANXA1—telencephalon—malignant glioma	0.0233	0.118	CbGeAlD
Amcinonide—ANXA1—medulla oblongata—malignant glioma	0.0183	0.0926	CbGeAlD
Amcinonide—ANXA1—midbrain—malignant glioma	0.0167	0.0846	CbGeAlD
Amcinonide—ANXA1—spinal cord—malignant glioma	0.0163	0.0825	CbGeAlD
Amcinonide—ANXA1—central nervous system—malignant glioma	0.0132	0.067	CbGeAlD
Amcinonide—ANXA1—cerebellum—malignant glioma	0.0129	0.0655	CbGeAlD
Amcinonide—ANXA1—brain—malignant glioma	0.0105	0.0532	CbGeAlD
Amcinonide—NR3C1—embryo—malignant glioma	0.00993	0.0503	CbGeAlD
Amcinonide—NR3C1—brainstem—malignant glioma	0.0091	0.0461	CbGeAlD
Amcinonide—NR3C1—telencephalon—malignant glioma	0.00808	0.0409	CbGeAlD
Amcinonide—NR3C1—medulla oblongata—malignant glioma	0.00635	0.0322	CbGeAlD
Amcinonide—NR3C1—AP-1 transcription factor network—MYB—malignant glioma	0.00632	0.00791	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00627	0.00785	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—SOX2—malignant glioma	0.00625	0.00782	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00615	0.0077	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—malignant glioma	0.00612	0.00766	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00609	0.00763	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCR3—malignant glioma	0.00586	0.00733	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—KNG1—malignant glioma	0.00585	0.00733	CbGpPWpGaD
Amcinonide—NR3C1—midbrain—malignant glioma	0.0058	0.0294	CbGeAlD
Amcinonide—ANXA1—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00578	0.00723	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00575	0.0072	CbGpPWpGaD
Amcinonide—NR3C1—spinal cord—malignant glioma	0.00566	0.0287	CbGeAlD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—malignant glioma	0.00563	0.00705	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00548	0.00686	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—BDKRB2—malignant glioma	0.00536	0.00671	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00523	0.00655	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.0051	0.00638	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00505	0.00633	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—KNG1—malignant glioma	0.00487	0.0061	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR4—malignant glioma	0.00477	0.00597	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00466	0.00583	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00464	0.00581	CbGpPWpGaD
Amcinonide—NR3C1—central nervous system—malignant glioma	0.00459	0.0233	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00459	0.00575	CbGpPWpGaD
Amcinonide—NR3C1—cerebellum—malignant glioma	0.00449	0.0227	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00443	0.00555	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00426	0.00533	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IFNG—malignant glioma	0.00414	0.00519	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.0041	0.00513	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—NCOR1—malignant glioma	0.0041	0.00513	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LATS2—malignant glioma	0.00408	0.0051	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.00404	0.00505	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—malignant glioma	0.00397	0.00497	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—malignant glioma	0.00395	0.00495	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—GJA1—malignant glioma	0.0039	0.00488	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00388	0.00485	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—malignant glioma	0.00385	0.00482	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.0038	0.00476	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—F2—malignant glioma	0.00378	0.00474	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—F2—malignant glioma	0.00373	0.00468	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—malignant glioma	0.0037	0.00463	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CASP3—malignant glioma	0.00369	0.00462	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL2—malignant glioma	0.00368	0.00461	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00367	0.0046	CbGpPWpGaD
Amcinonide—NR3C1—brain—malignant glioma	0.00365	0.0185	CbGeAlD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00361	0.00451	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00356	0.00446	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCR3—malignant glioma	0.00355	0.00444	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00352	0.0044	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—malignant glioma	0.00348	0.00436	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—HIF1A—malignant glioma	0.00346	0.00433	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00343	0.0043	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00338	0.00424	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00338	0.00423	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00333	0.00417	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—malignant glioma	0.00325	0.00407	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—BDKRB2—malignant glioma	0.00324	0.00406	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00321	0.00402	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00318	0.00398	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00317	0.00397	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00312	0.00391	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LATS1—malignant glioma	0.00309	0.00387	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.00303	0.00379	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00301	0.00377	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.003	0.00375	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HLA-A—malignant glioma	0.00298	0.00373	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—KNG1—malignant glioma	0.00295	0.00369	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—malignant glioma	0.00288	0.0036	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HIF1A—malignant glioma	0.00285	0.00357	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00284	0.00356	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.00284	0.00356	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—malignant glioma	0.00282	0.00353	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.0028	0.00351	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00279	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00276	0.00346	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.0027	0.00338	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR4—malignant glioma	0.0027	0.00338	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—malignant glioma	0.00268	0.00336	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00263	0.00329	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—NOTCH1—malignant glioma	0.00263	0.00329	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—APC—malignant glioma	0.00257	0.00322	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.00257	0.00322	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00254	0.00318	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00251	0.00314	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00251	0.00314	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.0025	0.00313	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.0025	0.00313	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00247	0.00309	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR4—malignant glioma	0.00245	0.00307	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—malignant glioma	0.00236	0.00296	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00236	0.00296	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00236	0.00295	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.00231	0.00289	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—malignant glioma	0.00222	0.00278	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.00218	0.00273	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00213	0.00266	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MDK—malignant glioma	0.00209	0.00261	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.00206	0.00258	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00205	0.00257	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.00204	0.00255	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCR3—malignant glioma	0.002	0.00251	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DTX1—malignant glioma	0.00199	0.00249	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.00199	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00196	0.00245	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.00194	0.00243	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00192	0.0024	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—F2—malignant glioma	0.00191	0.00239	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.00185	0.00231	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—BDKRB2—malignant glioma	0.00183	0.0023	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00182	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCR3—malignant glioma	0.00182	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00181	0.00227	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00179	0.00224	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.00177	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00177	0.00221	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.00175	0.00219	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00174	0.00218	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.00174	0.00218	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.00174	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.00169	0.00212	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.00167	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—KNG1—malignant glioma	0.00167	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—BDKRB2—malignant glioma	0.00166	0.00208	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.00166	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.00166	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.00165	0.00206	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00164	0.00205	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.00163	0.00204	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00161	0.00201	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SUFU—malignant glioma	0.00158	0.00198	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HEY2—malignant glioma	0.00156	0.00196	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.00156	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GFAP—malignant glioma	0.00153	0.00191	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KNG1—malignant glioma	0.00151	0.0019	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.00151	0.00189	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.0015	0.00188	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—malignant glioma	0.00148	0.00185	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SPHK1—malignant glioma	0.00148	0.00185	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR4—malignant glioma	0.00145	0.00181	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HEY1—malignant glioma	0.00145	0.00181	CbGpPWpGaD
Amcinonide—Triamcinolone—BCHE—malignant glioma	0.00144	0.379	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HIST1H3B—malignant glioma	0.00141	0.00176	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.00139	0.00174	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.00138	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00136	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—malignant glioma	0.00134	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MMP3—malignant glioma	0.00134	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAG2—malignant glioma	0.00128	0.00161	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.00123	0.00154	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.00113	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—H3F3A—malignant glioma	0.00109	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—F2—malignant glioma	0.00108	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCR3—malignant glioma	0.00108	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—malignant glioma	0.00105	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—YWHAE—malignant glioma	0.00105	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FLT1—malignant glioma	0.00104	0.0013	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DUSP6—malignant glioma	0.00104	0.0013	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—malignant glioma	0.00103	0.00129	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00103	0.00129	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAG1—malignant glioma	0.00102	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH3—malignant glioma	0.00102	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FBXW7—malignant glioma	0.001	0.00126	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.001	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BDKRB2—malignant glioma	0.000983	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—F2—malignant glioma	0.000979	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000974	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT2—malignant glioma	0.000944	0.00118	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—malignant glioma	0.000937	0.00117	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000934	0.00117	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000932	0.00117	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000923	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTPN11—malignant glioma	0.00092	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH2—malignant glioma	0.000914	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000907	0.00114	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000906	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KNG1—malignant glioma	0.000895	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT2—malignant glioma	0.000857	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK1—malignant glioma	0.000853	0.00107	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000853	0.00107	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.000844	0.00106	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2B6—malignant glioma	0.00084	0.221	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CD—malignant glioma	0.000824	0.00103	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000793	0.000993	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP3—malignant glioma	0.000793	0.000992	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000791	0.00099	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000791	0.00099	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN2B—malignant glioma	0.000786	0.000984	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—malignant glioma	0.000784	0.000982	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTK2—malignant glioma	0.000763	0.000955	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—malignant glioma	0.00076	0.000951	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000752	0.000942	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HES1—malignant glioma	0.00075	0.000938	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NCOR1—malignant glioma	0.000745	0.000933	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RAF1—malignant glioma	0.000735	0.00092	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—malignant glioma	0.000726	0.000909	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CB—malignant glioma	0.000718	0.000899	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFRA—malignant glioma	0.000714	0.000894	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000703	0.00088	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SPP1—malignant glioma	0.000693	0.000867	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—malignant glioma	0.00069	0.000864	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000683	0.000855	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000678	0.000849	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—malignant glioma	0.000663	0.174	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—malignant glioma	0.000659	0.000825	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TERT—malignant glioma	0.000657	0.000822	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFB—malignant glioma	0.000641	0.000803	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR1—malignant glioma	0.000638	0.000798	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—malignant glioma	0.000628	0.000786	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—malignant glioma	0.000608	0.000761	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—malignant glioma	0.000601	0.000752	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—F2—malignant glioma	0.000578	0.000724	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FN1—malignant glioma	0.000578	0.000724	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BAD—malignant glioma	0.000571	0.000715	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000571	0.000715	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH1—malignant glioma	0.000566	0.000708	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CD80—malignant glioma	0.000554	0.000694	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—malignant glioma	0.000553	0.000693	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—malignant glioma	0.000553	0.000693	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGF—malignant glioma	0.000547	0.000685	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTPN11—malignant glioma	0.000544	0.000681	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—malignant glioma	0.000543	0.143	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000539	0.000675	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000528	0.000661	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BRAF—malignant glioma	0.00052	0.000651	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT2—malignant glioma	0.000506	0.000634	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—malignant glioma	0.000504	0.000631	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000495	0.00062	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CD—malignant glioma	0.000487	0.000609	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000482	0.000603	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—malignant glioma	0.000476	0.000596	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF2—malignant glioma	0.000466	0.000583	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000444	0.000556	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—malignant glioma	0.000438	0.000548	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MDM2—malignant glioma	0.000436	0.000546	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAF1—malignant glioma	0.000434	0.000544	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—malignant glioma	0.00043	0.000538	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CB—malignant glioma	0.000424	0.000531	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—malignant glioma	0.000408	0.00051	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—malignant glioma	0.000394	0.000493	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—malignant glioma	0.00039	0.000488	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—malignant glioma	0.000389	0.000488	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000382	0.000478	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—malignant glioma	0.000369	0.000461	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—malignant glioma	0.000366	0.000459	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000362	0.000454	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—malignant glioma	0.000357	0.000448	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—malignant glioma	0.000331	0.000414	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—malignant glioma	0.000328	0.00041	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—malignant glioma	0.000316	0.0831	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000307	0.000385	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—malignant glioma	0.000305	0.000381	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—malignant glioma	0.000298	0.000373	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—malignant glioma	0.000281	0.000352	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH1—malignant glioma	0.000275	0.000344	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—malignant glioma	0.00026	0.000325	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—malignant glioma	0.000259	0.000324	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—malignant glioma	0.00025	0.000313	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—malignant glioma	0.000211	0.000264	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—malignant glioma	0.000148	0.000185	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—malignant glioma	0.000103	0.000129	CbGpPWpGaD
